Holdings

Symbol Grade Price % Change Allocation
TEF D 2.24 1.91
VOD B 1.55 1.89
RDS.B D -0.56 1.88
LAWS D -3.12 1.81
OTEX A -0.18 1.80
SNY B 1.20 1.70
GSK B 0.16 1.65
RIO C 1.21 1.64
NVS C 0.94 1.53

Recent News for AAM S&P Developed Markets High Dividend Value ETF & its Holdings

Date Stock Title
Apr 17 GSK Benzinga's Bulls And Bears Of The Week: Alphabet, Coinbase, GE, Quantumscape, Tesla And More
Apr 17 SNY Moderna cuts UK COVID vaccine deliveries as pregnant women told mRNA jabs are safe
Apr 17 GSK Could Vir Biotechnology Be a Millionaire Maker Stock?
Apr 17 RDS.B The Tech Tracking Down Methane Leaks
Apr 16 NVS Novartis (NVS) Collaborates with Roche for API of RA Drug Actemra
Apr 16 RDS.B Oil Demand Is Finally Bouncing Back
Apr 16 GSK The push to vaccinate farm workers against COVID-19
Apr 16 RIO Surging iron ore prices hit decade highs on rising steel demand
Apr 16 GSK Vaccinating kids will be very important in getting to herd immunity: Doctor
Apr 16 SNY Vaccinating kids will be very important in getting to herd immunity: Expert
Apr 16 RDS.B Equinor (EQNR) Pushes Tanzania to Act On Suspended LNG Project
Apr 16 GSK Glaxo Jumped on Report of Activist Stake. But What Could Elliott Management Do?
Apr 16 GSK Elliott Entry at Glaxo Piles Pressure on CEO to Speed Turnaround
Apr 16 GSK Activist Investor Elliott Builds Stake in GlaxoSmithKline, According to Reports
Apr 16 SNY Pfizer CEO says a third vaccine dose is likely, Moderna updates booster shot timeline
Apr 16 GSK Pfizer CEO says a third vaccine dose is likely, Moderna updates booster shot timeline
Apr 16 RDS.B Shell (RDS.A) to Hold Energy Transition Strategy Advisory Vote
Apr 16 RIO The Zacks Analyst Blog Highlights: BHP Group, Rio Tinto, Southern Copper and Freeport-McMoRan
Apr 16 GSK Glaxo (GSK)/ Vir Biotech COVID-19 Antibody Under Review in EU
Apr 16 GSK Pharma Stock Roundup: JNJ's COVID-19 Vaccine Woes, MRK Ends COVID-19 Drug Development
The investment seeks to track the total return performance, before fees and expenses, of the S&P Developed Ex-U.S. Dividend and Free Cash Flow Yield Index. Under normal circumstances, at least 80% of the fund's total assets (exclusive of any collateral held from securities lending) will be invested in the component securities of the index and depositary receipts representing index components. The index is designed to provide exposure to the constituents of the S&P Developed BMI Ex-U.S. & Korea LargeMidcap Index that exhibit both high dividend yield and sustainable dividend distribution characteristics, while maintaining diversified sector exposure.
Exchange Traded Fund ETF Dividend Yield Midcap Free Cash Flow S&P Developed
Back to the Main DMDV Page...